Stay updated on IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.

Latest updates to the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page
- Check4 days agoChange Detected- The page now shows a new Melanoma topic tag and a MedlinePlus Genetics related topics link, which are minor metadata/navigation updates that do not affect core study data. - To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page's revision indicator was updated from v3.2.0 to v3.3.2, reflecting a minor version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedRemoved non-core items: government funding status notice and topic links (Melanoma; MedlinePlus Genetics). This does not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check40 days agoChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the page's related topics section.SummaryDifference0.2%

- Check47 days agoChange DetectedTwo screenshots show only layout and styling tweaks with the study details remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check54 days agoChange DetectedMelanoma and MedlinePlus Genetics related topics were added to the study page to enhance navigation and topic discovery. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.